The Mechanistic Link Between Tau-Driven Proteotoxic Stress and Cellular Senescence in Alzheimer's Disease

Karthikeyan Tangavelou1, Kiran Bhaskar1,2

  • 1Department of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.

Insights

Alzheimer's disease involves tau protein buildup and impaired degradation, leading to cellular stress and brain atrophy. This review explores the link between tau, proteotoxic stress, and cellular senescence in AD.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Tau protein hyperphosphorylation and misfolding in Alzheimer's disease (AD) lead to its dissociation from microtubules.
  • Multiple cellular degradation pathways, including proteasomes and autophagy, are involved in tau clearance.
  • Impaired aggrephagy leads to neurofibrillary tangle (NFT) formation and recruitment of chaperones like VCP and HSP70 for tau degradation via the ubiquitin-proteasome system (UPS).

Purpose of the Study:

  • To review the sequential failure of tau degradation mechanisms in AD.
  • To elucidate the mechanistic link between tau-driven proteotoxic stress and cellular senescence.
  • To summarize evidence on how impaired tau clearance contributes to AD pathogenesis.

Main Methods:

  • Comprehensive literature review of studies on tau degradation pathways in AD.
  • Analysis of mechanisms linking tau pathology to proteotoxic stress and cellular senescence.
  • Synthesis of evidence on tau secretion, uptake, and subsequent cellular responses.

Main Results:

  • Failure in tau degradation pathways contributes to tau accumulation and extracellular secretion.
  • Secreted tau seeds pathology in various brain cells, inducing proteotoxic stress.
  • Proteotoxic stress triggers cellular senescence, characterized by senescence-associated secretory phenotype (SASP) factors, leading to brain atrophy.

Conclusions:

  • Tau degradation failure is a critical early event in AD.
  • Tau-driven proteotoxic stress and cellular senescence are mechanistically linked, contributing to neurodegeneration.
  • Understanding these pathways offers potential therapeutic targets for AD.

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
37
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
814
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.2K